LB Pharmaceuticals Inc Common StockLBRX

$30.00-0.05 (-0.17%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$847M

Small-cap

+18073%

2025 — today

10-Year Price

+62%

2025 — today

52-Week Range

$14.61$32.88

Current $30.00· 84%

This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.

Valuation in context

P/E ratio

-1.4

N/A

Not meaningful — company is unprofitable

P/B ratio

2.2

Historically pricey

Historically pricey — last 10 years

FCF Yield

-6.1%

Above average

Above the 10-year average

Free · No credit card needed

Get alerted when LBRX is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.